ST-Elevation Myocardial Infarction (STEMI): Diagnostic Criteria and Treatment
STEMI is diagnosed by persistent ST-segment elevation at the J point in at least 2 contiguous leads (with specific voltage thresholds of ≥1 mm in all leads except V2-V3, where thresholds are ≥2.5 mm for men <40 years, ≥2 mm for men ≥40 years, and ≥1.5 mm for women) in the setting of characteristic chest pain, and requires immediate reperfusion therapy within 120 minutes of diagnosis to reduce mortality and morbidity. 1
Diagnostic Criteria
ECG Criteria
- ST-segment elevation at the J point in at least 2 contiguous leads
- Specific voltage thresholds:
- ≥1 mm in all leads except V2-V3
- For leads V2-V3:
- ≥2.5 mm for men <40 years
- ≥2 mm for men ≥40 years
- ≥1.5 mm for women 1
Clinical Presentation
- Characteristic chest pain/discomfort lasting ≥10 minutes
- Pain typically described as pressure or heaviness
- May radiate to the neck, jaw, or left arm 1
Laboratory Testing
- Cardiac troponin is the preferred biomarker
- Important: Troponin may be initially negative and should not delay reperfusion therapy
- Should be measured at presentation and 6-12 hours after symptom onset if initially negative 1
STEMI Equivalents
Up to 30% of patients with acute coronary occlusion may not meet classic STEMI criteria. Important STEMI equivalents to recognize include:
- De Winter T-waves (upsloping ST depression with tall symmetric T waves in precordial leads)
- Wellens syndrome (deep T-wave inversions in anterior leads)
- Posterior MI (ST depression in V1-V3 with tall R waves)
- New left bundle branch block with appropriate clinical context
- Hyperacute T-waves 2
Initial Management
- Obtain 12-lead ECG within 10 minutes of first medical contact 1
- Administer aspirin 160-325 mg (chewed or crushed for rapid absorption) immediately 1
- Establish IV access and cardiac monitoring
- Determine reperfusion strategy within 10 minutes of STEMI diagnosis 1
Reperfusion Strategy
Primary PCI
- Preferred when it can be performed within 120 minutes of STEMI diagnosis
- Requires skilled PCI facility with surgical backup 1
- Antiplatelet therapy:
- Aspirin plus prasugrel or ticagrelor 1
- Anticoagulation:
- Unfractionated heparin (alternatives: enoxaparin or bivalirudin) 1
Fibrinolysis
- Preferred when:
- Early presentation (<3 hours)
- PCI cannot be performed within 120 minutes
- No contraindications to fibrinolysis exist 1
- Antiplatelet therapy:
- Aspirin plus clopidogrel 1
- Anticoagulation:
- Enoxaparin (alternative: unfractionated heparin) 1
- Transfer to PCI-capable facility after fibrinolysis for routine early angiography (3-24 hours)
Post-STEMI Care
Medication Therapy
- Dual antiplatelet therapy (DAPT):
- Aspirin plus P2Y12 inhibitor for 1 year 1
- Beta-blockers for all patients without contraindications 1
- ACE inhibitors/ARBs:
- Recommended for patients with reduced ejection fraction, heart failure, or diabetes 1
- High-intensity statin therapy for all patients 1
Secondary Prevention
- Cardiac rehabilitation
- Smoking cessation
- Blood pressure control
- Diabetes management
- Regular physical activity 1
Common Pitfalls to Avoid
- Delaying ECG interpretation or waiting for biomarker results before initiating reperfusion therapy
- Misinterpreting STEMI equivalents
- Overlooking reperfusion in elderly patients
- Delaying transfer for primary PCI when indicated 1
- Failing to recognize symptoms promptly, leading to delayed presentation 3
- Insufficient public awareness about STEMI symptoms and the "time is muscle" concept 3
Special Considerations
In resource-limited settings, challenges may include:
- Limited access to ECG or cardiac biomarker testing
- Delayed access to medical services
- Lack of PCI-capable facilities within appropriate timeframes 3
In these cases:
- Clinical judgment becomes crucial
- Fibrinolysis may be the more accessible reperfusion strategy
- Development of STEMI networks and standardized protocols can help improve outcomes 3, 4
Remember that early diagnosis and immediate reperfusion are the most effective ways to limit myocardial ischemia, reduce infarct size, and improve survival outcomes 4, 5.